as on December 13, 2025 at 2:29 am IST
Day's Low
Day's High
0.39%
Downside
1.78%
Upside
52 Week's Low
52 Week's High
51.18%
Downside
12.82%
Upside
Check Curevac market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-0.5416
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.24%
PE Ratio (TTM)
7.76
Industry PE ratio
-0.35549019607843135
PEG Ratio
0EBITDA
193.7M
Revenue (TTM)
70.7M
Profit Margin
182.11%
Return On Equity TTM
40.22%
Track how Curevac P/E has moved over time to understand its valuation trends.
Curevac in the last 5 years
Lowest (-84.12x)
December 31, 2020
Industry (-0.36x)
December 13, 2025
Today (7.76x)
December 13, 2025
Highest (9.64x)
September 30, 2024
Today’s Price to Earnings Ratio: 7.76x
Compare market cap, revenue, PE, and other key metrics of Curevac with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | -95.72% | 7.76 | 182.11% | |
| BUY | $42.0B | 393.88% | -16.34 | -264.83% | |
| BUY | $54.5B | 206.63% | 1422.86 | 1.36% | |
| BUY | $114.3B | 101.65% | 31.25 | 31.35% | |
| BUY | $79.2B | 54.51% | 17.42 | 32.13% |
The Curevac stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Curevac investment value today
Current value as on today
₹1,67,205
Returns
₹67,205
(+67.2%)
Returns from Curevac Stock
₹60,443 (+60.44%)
Dollar Returns*
₹6,762 (+6.76%)
Based on 15 analysts
66.67%
Buy
26.67%
Hold
6.67%
Sell
Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Curevac. Average target price of $5.41
Get share price movements and forecasts by analysts on Curevac.
What analysts predicted
6.28%UPSIDE
Target Price
$5.41
Current Price
$5.07
Analyzed by
15 Analysts
Target
$5.41
Curevac target price $5.41, a slight upside of 6.28% compared to current price of $5.07. According to 15 analysts rating.
Search interest for Curevac Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:38% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 26 November
Wed, 06:24 PM
-CureVac shareholders overwhelmingly approved proposals for BioNTech's exchange offer at the extraordinary general meeting.
Thu, 03:28 AM
-BioNTech's exchange offer for CureVac shares approved; expires December 3, 2025, with an exchange ratio of 0.05363 BioNTech ADS per CureVac share.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -59.56M → 338.04M (in $), with an average increase of 117.6% per quarter
Price Rise
![]()
In the last 1 year, CVAC stock has moved up by 59.8%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 893.0K → 493.90M (in $), with an average increase of 64.0% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 175.0% return, outperforming this stock by 115.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 885.5% return, outperforming this stock by 915.1%
| Organisation | Curevac |
| Headquarters | Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076 |
| Industry | Health Technology |
| CEO | Dr. Alexander Zehnder M.B.A., M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Alexander Zehnder M.B.A., M.D. | CEO, MD & Member of Management Board |
Mr. Axel-Sven Malkomes | CFO & Member of Executive Board |
Dr. Malte Greune Ph.D. | COO, Member of Management Board & MD |
Mr. Thaminda Ramanayake | Chief Business Officer & Member of Executive Board |
Dr. Myriam Mendila M.D. | Chief Scientific Officer, Head of R&D, MD & Member of the Management Board |
Dr. Sarah Fakih | Vice President of Corporate Communications & Investor Relations |
Mr. Marco Rau L.L.M., Ph.D. | General Counsel |
Slavica Stevanovic-Heck | Head of Human Resources |
Dr. Ulrike Gnad-Vogt M.D., Ph.D. | Senior VP & Area Head of Oncology |
Dr. Patrick Baumhof | Senior Vice President of Technology |
Curevac share price today is $5.07 as on at the close of the market. Curevac share today touched a day high of $5.16 and a low of $5.05.
Curevac share touched a 52 week high of $5.72 on and a 52 week low of $2.48 on . Curevac stock price today i.e. is closed at $5.07,which is 11.36% down from its 52 week high and 104.85% up from its 52 week low.
Curevac market capitalisation is $0.00T as on .
Indian investors can start investing in Curevac (CVAC) shares with as little as ₹90.544 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.44 in Curevac stock (as per the Rupee-Dollar exchange rate as on ).
Based on Curevac share’s latest price of $5.07 as on December 13, 2025 at 2:29 am IST, you will get 1.9724 shares of Curevac. Learn more about
fractional shares .
Curevac stock has given -95.72% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?